| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.062 | 0.06 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.08 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.08 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.09 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.12 | 0.09 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.1 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |